Profile

PhD, University of California, Santa Barbara
MA, University of California, Santa Barbara






Title


Yr Title Project-Sub Proj Pubs
2022 Data Management & Analysis Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma 1U19AI168643-01-7846
2021 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 3U19AI118608-05S6-9334 6
2021 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 3U19AI118608-05S5-7024 6
2021 Patient Safety Event Surveillance Using Machine Learning and Free Text Clinical Notes 5R01HS026246-03
2021 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 5U19AI118608-05-7024 6
2020 Patient Safety Event Surveillance Using Machine Learning and Free Text Clinical Notes 5R01HS026246-02
2020 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 5U19AI118608-04-7024 6
2019 Patient Safety Event Surveillance Using Machine Learning and Free Text Clinical Notes 1R01HS026246-01A1
2019 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 5U19AI118608-03-7024 6
2018 Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity 5U19AI118608-02-7024 6
Showing 10 of 13 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Morrocchi E, Pighi C, Pascucci GR, Cotugno N, Medri C, Amodio D, Colagrossi L, Ruggiero A, Manno EC, Casamento Tumeo C, Bernardi S, Smolen KK, Perno CF, Ozonoff A, Rossi P, Levy O, Palma P. Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S51-S60. PMID: 35738253; PMCID: PMC9278233; DOI: 10.1093/cid/ciac408;
     
  2. Nanishi E, Angelidou A, Rotman C, Dowling DJ, Levy O, Ozonoff A. Precision Vaccine Adjuvants for Older Adults: A Scoping Review. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S72-S80. PMID: 35439286
     
  3. Top KA, Chen RT, Levy O, Ozonoff A, Carleton B, Crawford NW, Creech CB, Kochhar S, Poland GA, Gutu K, Cutland CL. Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S11-S17. PMID: 35680552; PMCID: PMC9376276; DOI: 10.1093/cid/ciac407;
     
  4. Chew K, Lee B, van Haren SD, Nanishi E, O'Meara T, Splaine JB, DeLeon M, Soni D, Seo HS, Dhe-Paganon S, Ozonoff A, Smith JA, Levy O, Dowling DJ. Adjuvant Discovery via a High Throughput Screen using Human Primary Mononuclear Cells. bioRxiv. 2022 Jul 11. PMID: 35860217; PMCID: PMC9298130; DOI: 10.1101/2022.06.17.496630;
     
  5. Diray-Arce J, Angelidou A, Jensen KJ, Conti MG, Kelly RS, Pettengill MA, Liu M, van Haren SD, McCulloch SD, Michelloti G, Idoko O, Kollmann TR, Kampmann B, Steen H, Ozonoff A, Lasky-Su J, Benn CS, Levy O. Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro. Cell Rep. 2022 05 03; 39(5):110772. PMID: 35508141; PMCID: PMC9157458; DOI: 10.1016/j.celrep.2022.110772;
     
  6. Ruggiero A, Pascucci GR, Cotugno N, Domínguez-Rodríguez S, Rinaldi S, Tagarro A, Rojo P, Foster C, Bamford A, De Rossi A, Nastouli E, Klein N, Morrocchi E, Fatou B, Smolen KK, Ozonoff A, Di Pastena M, Luzuriaga K, Steen H, Giaquinto C, Goulder P, Rossi P, Levy O, Pahwa S, Palma P. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy. Front Immunol. 2022; 13:860418. PMID: 35432380; PMCID: PMC9009387; DOI: 10.3389/fimmu.2022.860418;
     
  7. Nanishi E, Levy O, Ozonoff A. Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review. Hum Vaccin Immunother. 2022 Nov 30; 18(5):2045857. PMID: 35240940; PMCID: PMC9196671; DOI: 10.1080/21645515.2022.2045857;
     
  8. Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Cavazzoni CB, Brook B, Barman S, Chen J, Diray-Arce J, Doss-Gollin S, De Leon M, Prevost-Reilly A, Chew K, Menon M, Song K, Xu AZ, Caradonna TM, Feldman J, Hauser BM, Schmidt AG, Sherman AC, Baden LR, Ernst RK, Dillen C, Weston SM, Johnson RM, Hammond HL, Mayer R, Burke A, Bottazzi ME, Hotez PJ, Strych U, Chang A, Yu J, Sage PT, Barouch DH, Dhe-Paganon S, Zanoni I, Ozonoff A, Frieman MB, Levy O, Dowling DJ. An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci Transl Med. 2022 Jan 26; 14(629):eabj5305. PMID: 34783582; DOI: 10.1126/scitranslmed.abj5305;
     
  9. Milliren CE, Bailey G, Graham DA, Ozonoff A. Relationships Between Pediatric Safety Indicators Across a National Sample of Pediatric Hospitals: Dispelling the Myth of the "Safest" Hospital. J Patient Saf. 2022 Jun 01; 18(4):e741-e746. PMID: 35617599; PMCID: PMC9136151; DOI: 10.1097/PTS.0000000000000938;
     
  10. Al-Samkari H, Ozonoff A, Landschaft A, Kimia R, Harper MB, Croteau SE, Kimia AA. Utility of Blood Cultures and Empiric Antibiotics in Febrile Pediatric Hemophilia Patients With Central Venous Access Devices. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1531-e1534. PMID: 32349076; DOI: 10.1097/PEC.0000000000002106;
     
Showing 10 of 238 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 39 publications over 9 distinct years, with a maximum of 8 publications in 2015 and 2016

YearPublications
20051
20062
20072
20082
20144
20158
20168
20176
20186

Contact for Mentoring: